All In Biotech

Investigational drug · Phase 3

Lutikizumab

Also called: ABT-981

Not approved by FDA. In 8 industry-sponsored Phase 2 or 3 trials that are active or finished in the last two years, most often for Hidradenitis Suppurativa, Atopic Dermatitis, Rheumatoid Arthritis.

Phase 3

Last checked: Nov 20, 2026Latest source record: Nov 9, 2026 (newest trial update)Source: ClinicalTrials.govMethods & limitations

Highest phase

Phase 3

Industry-sponsored trials

Phase 2 and 3 trials

8

8 still active

All registered trials

12

Any phase or sponsor naming "Lutikizumab"

First trial start

2021

Dec 28, 2021

Sponsors

Lead sponsors of its Phase 2 and 3 trials.

All registered trials by phase

Every ClinicalTrials.gov drug study naming "Lutikizumab", any sponsor or status.

Conditions studied

As listed on its trial records.

  • Hidradenitis Suppurativa
  • Atopic Dermatitis
  • Rheumatoid Arthritis
  • Psoriatic Arthritis
  • Ulcerative Colitis
  • Crohn's Disease

Approved drugs for the same conditions: Rheumatoid arthritis · Psoriatic arthritis · Atopic dermatitis (eczema) · Crohn's disease · Ulcerative colitis · Hidradenitis suppurativa · Immunology and inflammation · Dermatology

Largest trials

Live from ClinicalTrials.gov: studies naming "Lutikizumab" as an intervention, largest first.

All trials

Newest research

PubMed records naming it or its code names, newest first.

All 16 on PubMed

Also in development for Hidradenitis Suppurativa

  • ZasocitinibTAK- 279, NDI-034858Phase 317 trials

    Takeda · Plaque Psoriasis, Psoriatic Arthritis, Crohn's Disease

  • MK-7240PRA023, TulisokibartPhase 310 trials

    Merck & Co. · Ulcerative Colitis, Psoriatic Arthritis, Crohn's Disease

  • OlatorepatideHS-20094Phase 38 trials

    Jiangsu Hansoh Pharmaceutical Co., Ltd. · Type 2 Diabetes, Overweight or Obesity, Overweight or Obesity Without Diabetes

  • SonelokimabPhase 37 trials

    MoonLake Immunotherapeutics AG · Hidradenitis Suppurativa, Arthritis, Psoriatic

  • brivekimigSAR442970Phase 25 trials

    Sanofi · Focal Segmental Glomerulosclerosis, Glomerulonephritis Minimal Lesion, Type 1 Diabetes Mellitus

  • MAS825ArumakimigPhase 24 trials

    Novartis · NLRC4-GOF, AIFEC (Autoinflammation With Infantile Enterocolitis), XIAP Deficiency, CDC42 Mutations, Still´s Disease, VEXAS Syndrome

  • EltrekibartLY3041658Phase 22 trials

    Eli Lilly · Ulcerative Colitis, Ulcerative Colitis Chronic, Hidradenitis Suppurativa

  • HB0043Phase 22 trials

    Shanghai Huaota Biopharmaceutical Co., Ltd. · Acne Vulgaris, Hidradenitis Suppurativa

Names are merged from how sponsors list this drug on ClinicalTrials.gov, so an alias can occasionally belong to a related compound. Development status changes faster than registry records do. More from AbbVie.

For information only. Nothing on this page is investment, legal, tax or medical advice, and nothing here is an offer to sell or a solicitation of an offer to buy any security. The data comes from public government sources, which can be incomplete, delayed or wrong. Check the original record before relying on it.